Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
5.16
-0.30 (-5.49%)
At close: Nov 20, 2024, 4:00 PM
5.17
+0.01 (0.19%)
After-hours: Nov 20, 2024, 7:53 PM EST
Annexon Employees
Annexon had 71 employees as of December 31, 2023. The number of employees decreased by 9 or -11.25% compared to the previous year.
Employees
71
Change (1Y)
-9
Growth (1Y)
-11.25%
Revenue / Employee
n/a
Profits / Employee
-$1,654,944
Market Cap
550.02M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 71 | -9 | -11.25% |
Dec 31, 2022 | 80 | 19 | 31.15% |
Dec 31, 2021 | 61 | 13 | 27.08% |
Dec 31, 2020 | 48 | 24 | 100.00% |
Dec 31, 2019 | 24 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Phathom Pharmaceuticals | 452 |
OrthoPediatrics | 247 |
Butterfly Network | 225 |
AnaptysBio | 117 |
Stoke Therapeutics | 110 |
ORIC Pharmaceuticals | 100 |
Immunome | 55 |
Tectonic Therapeutic | 44 |
ANNX News
- 5 days ago - Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 days ago - Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones - GlobeNewsWire
- 7 days ago - Annexon Biosciences to Present at the Jefferies London Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Annexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting - GlobeNewsWire
- 7 weeks ago - Director William Carson Acquires 3,200 Shares of Annexon Inc (ANNX) - GuruFocus
- 3 months ago - Speculative "Buy" Rating On Annexon: Evaluating The Potential Of ANX005 For GBS - Seeking Alpha
- 4 months ago - Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Annexon to Present Additional Phase 2 Data Showing Preservation of Visual Function and Structure by ANX007 in Geographic Atrophy at the 42nd ASRS Annual Scientific Meeting - GlobeNewsWire